ASTMH 2017

66th Annual Meeting

November 5-9, 2017
Baltimore, Maryland, USA

This annual meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students and all health care providers working in the fields of tropical medicine, hygiene and global health. 

DNDi took part in symposia, poster and oral presentation sessions at the meeting.

Download DNDi@ASTMH flyer


Chagas disease: Regional differences in clinical research and patient care

Date: Wednesday, November 8, 2017

Organizer: Symposium Organizer: Sergio Sosa Estani, Drugs for Neglected Diseases initiative – Latin America, Rio de Janeiro, Brazil

Real-world management of heart failure in Chagas disease: insights from the BENEFIT Trial
Carlos Morillo, Alberta Health Services, Calgary, AB, Canada

Update current clinical trials for improving etiological treatment of Chagas disease
Fabiana Barriera, Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil

Regional differences in congenital transmission of T. cruzi in Latin America
Pierre Buekens, Tulane University, New Orleans, LA, United States
Decision-making algorithm for the evaluation of therapeutic response in the health care system
Yanina Sguassero, Centro Rosarino de Estudios Perinatales, Rosario, Argentina


Immigration and Chagas disease: Barriers to access to treatment and new challenges in the US, Europe and Latin America

Date: Wednesday, November 8, 2017

Organizer: Sheba K Meymandi, Center of Excellence for Chagas Disease at Olive View-UCLA Medical Center, Sylmar, CA, United States

Migrants, infectious diseases and the political economic landscape in 2017
Peter J Hotez, Baylor University, Houston, TX, United States

Immigration and Chagas disease in Europe: new challenges
Joaquim Gascon, Institut de Salut Global de Barcelona, Barcelona, Spain

Chagas disease in the Bolivian population of São Paulo, Brazil
Maria A Shikanai-Yasuda, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
Chagas disease in a time of immigrant backlash: challenges for expanding access to treatment in Los Angeles and beyond
Colin J Forsyth, Drugs for Neglected Diseases initiative, New York, NY, United States


Oral Presentations

Date: Monday, November 6, 2017

Projected number of people with onchocerciasis-loiasis co-infection in Africa, 1995-2025
Vinkeles Melchers NVS, Tekle AH, Coffeng LE, Pion SDS, Zouré HGM, Pedrique B, Boussinesq M, Wanji S, Remme JHF, Stolk WA

Building a visceral leishmaniasis data-sharing platform to optimize treatment and inform future research
Guerin PJ, Otieno M, Alvar J


Date: Tuesday, November 7, 2017

ABBV-4083: a clinical candidate for the treatment of onchocerciasis – efficacy in the L. sigmodontis rodent model
Bloemker D, Hübner MP, Scandale I, von Geldern T, Marsh K, Taylor MJ, Kempf D, Hoerauf

Identification of potential clinical candidates with macrofilaricidal efficacy for the treatment of onchocerciasis
Hübner MP, Hoerauf A, Blömker D, Townson S, Gokool S, Martin C, Vallarino-Lhermitte N, Chojnowski A, Kreiss T, Prorok M, Siekierka J, Khetani V, Camardo J, Canan S, Scandale I, Hawryluk N


Poster Presentations

Designing antifilarial drug trials using clinical trial simulators
Walker M, Milton P, Monnot F, Pedrique B, Basáñez MG

Surrogate markers of cure for Chagas disease in children treated with Benznidazole
Ruiz-Lancheros E, Chatelain E, Bournissen F, Moroni S, Moscatelli G, Altcheh J, Ndao M

Comparison of the in vitro susceptibility to emodepside of microfilariae, third stage larvae and adult worms of related filarial nematodes
Kulke D, Townson S, Bloemker D, Frohberger S, Specht S, Scandale I, Glenschek-Sieberth M, Harder A, Hoerauf A, Hübner MP




More information: